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ABSTRACT
International Journal of Exercise Science 10(2): 246-257, 2017. Improvements in indices

of vascular health and endothelial function have been inversely associated with hypertension, a
risk factor for cardiovascular disease (e.g., myocardial infarction, stroke, and heart failure), renal
failure, and mortality. Aerobic exercise training (AEXT) has been positively associated with
improvements in clinical health values, as well as vascular health biomarkers, and endothelial
function. The purpose of this study was to evaluate whether measures of exercise adherence were
related to clinical outcome measures and indices of vascular health subsequent to a 6 -month AEXT
intervention in a middle-to-older aged African American cohort. Following dietary stabilization,
sedentary, apparently healthy, African American adults (40 - 71 y/o) underwent baseline testing
including blood pressure, flow-mediated dilation (FMD) studies, fasting blood sampling, and
graded exercise testing. Upon completion of a supervised 6 -month AEXT intervention,
participants repeated all baseline tests. Exercise adherence was measured three ways: exercise
percentage, exercise volume, and exercise score. There were no significant correlations between the
changes in the vascular health biomarkers of the participants and any of the adherence measures.
In addition, there were no significant correlations between any of the adherence measures and the
clinical values of the participants that had been significantly changed pre-post-AEXT. Participants
improved their clinical and vascular health and decreased risk factors
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for hypertension and cardiovascular disease regardless of their level of adherence to AEXT. Future
studies should continue to accurately quantify adherence in order to assess the exercise dose for
improvements in vascular and clinical health.

KEY WORDS: Physical inactivity, cardiovascular risk factors, endothelial
dysfunction, endothelial adaptations, clinical intervention, exercise prescription
INTRODUCTION
Physical inactivity is a modifiable risk factor for the development of numerous chronic diseases
including obesity, Type 2 diabetes, hypertension, cardiovascular disease, and certain types of
cancers (4, 36). Studies have demonstrated that chronic mild-to-moderate intensity aerobic
exercise elicits improvements in multiple traditional cardiovascular risk factors (e.g., fasting
glucose, blood lipids, blood pressure) (5, 19, 34), as well as vascular health biomarkers (20), and
endothelial function (2, 17, 21). These documented improvements of indices pertaining to
vascular health and endothelial function have included increased flow -mediated dilation
(FMD), nitric oxide (NO), and interleukin-10 (IL-10), as well as decreased endothelial
microparticles (EMP), C-reactive protein (CRP), and interleukin-6 (IL-6). These improvements
are particularly significant because endothelial dysfunction has been considered to be an initial
step in the pathogenic process underlying atherosclerosis development and has been associated
with hypertension, a risk factor for cardiovascular disease (e.g., myocardial infarction, stroke,
and heart failure), renal failure, and mortality (7, 28). Aerobic exercise training (AEXT) has been
associated with favorable endothelial adaptations due to increased blood flow from shear stress
(9, 22, 25, 31). In addition, the subsequent improvements in clinical health values and vascular
health biomarkers may lead to the development of preventive measures to reduce hypertension
and the risk of cardiovascular disease.
According to the U.S. Department of Health and Human Services (DHHS), African American
adults are 40% more likely to have hypertension than their Caucasian counterparts (27). Given
the disparate prevalence of the condition among African Americans, as well as the welldocumented influence of aerobic exercise on vascular health, particular attention should be
given to the implementation and evaluation of exercise programs as a clinical intervention for
this population.
Exercise adherence, the degree to which an individual complies with his or her program, is
central to evaluating the efficacy of exercise interventions and ultimately addressing health
disparities (23). Adherence may be influenced by a range of factors, including those related to
the individual (e.g., demographic and psychological characteristics), the environment (e.g.,
social support and accessibility), as well as the behavior itself (e.g., intensity, duration, and
perceived effort) (33). Studies indicate that greater levels of adherence yield favorable outcomes
(12, 13, 15); likewise, without adherence to exercise protocols, physiological improvements may
be attenuated or may not occur (23, 26, 36). Adherence to exercise prescriptions is often
mentioned, yet seldom reported in clinical interventions. Therefore, exercise prescriptions and
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subsequent improvements cannot be sufficiently evaluated unless adherence is accurately
measured.
In clinical interventions, exercise adherence is often measured as a dichotomous variable, where
one either completes the treatment (i.e., adheres), or does not complete the treatment (i.e., does
not adhere). Studies have investigated the effects of AEXT on improvements in clinical and
vascular health outcomes (4, 16); however, few have examined the role that varied levels of
adherence may play in this process, particularly among at-risk populations. The purpose of this
study was to evaluate whether measures of exercise adherence were related to clinical outcome
measures and indices of vascular health subsequent to a 6-month AEXT intervention in a
middle-to-older aged African American cohort.
METHODS
Participants
Participants included in the study were middle-to-older aged (40 - 71 y/o) African Americans
at low-to-moderate risk for cardiovascular disease as previously described (2) and otherwise
apparently healthy as defined by the American College of Sports Medicine (ACSM) (1).
Protocol
Baseline testing included office blood pressure measurements, FMD studies, fasting blood
sampling, and graded exercise testing. Clinical laboratory values measured included body mass
index (BMI), maximal oxygen uptake (VO 2max), systolic blood pressure (SBP), diastolic blood
pressure (DBP), total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density
lipoprotein cholesterol (HDL-C), triglycerides, and fasting blood glucose.
EMP, CRP, IL-10, IL-6, and NO were measured in the plasma samples, and FMD was measured
in the brachial artery as previously described (2, 14, 35). Participants repeated all baseline tests
at the conclusion of the intervention.
Participants engaged in a 6-month (24-week) aerobic exercise program under direct supervision
of lab personnel, 3x/week, starting with 20 minutes of exercise per session at an intensity
equivalent to 50% of VO 2max. Training duration was increased 5 minutes each week until 40
minutes of exercise at 50% of VO 2max was achieved. Upon achieving 40 minutes of exercise,
training intensity was increased 5% each week until 65% of VO 2max was achieved. By week
eight, participants reached the desired exercise duration of 40 minutes and an intensity at 65%
of VO2max, which they maintained as their exercise prescription for the remainder of the study.
Exercise modes included treadmill walking/jogging, stair stepping, stationary cycling, elliptical
cross-training, and rowing and arm ergometry. The participants used heart rate monitors during
exercise in order to monitor exercise intensity, and study personnel recorded heart rates every
10 minutes to ensure adherence to the prescribed training program. Cardiovascular fitness was
determined by a submaximal treadmill test and individualized exercise prescriptions were
developed for the AEXT intervention as described previously (2).
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Measures of adherence were calculated to account for physiological adaptations that may occur
during exercise training as well as detraining effect. Three different adherence measures were
calculated including exercise percentage, exercise volume, and exercise score. Exercise
percentage was calculated by taking the 24-week program divided by the actual number of
weeks that it took each participant to complete the program up to a maximum of 52 weeks (1
year). Participants were required to repeat a week’s exercise prescription if they did not attend
at least two sessions in a given week and maintain a 60% minimum exercise percentage. In order
to demonstrate whether a higher volume of exercise elicited greater physiological adaptations,
exercise volume was calculated by adding the total number of minutes that the subject
completed during the training program. As already noted, relative intensity remained constant
between the participants. Lastly, exercise score was calculated by taking the exercise volume
divided by the number of weeks it took each participant to complete the program. This
adherence measure considered current guidelines for exercise including frequency, intensity,
and duration (1), and when compared to adherence volume, this measurement specifically
considered whether frequency of exercise influenced physiological response.
Statistical Analysis
Among the 42 participants who completed the 6-month AEXT intervention, the data used in the
statistical analysis for each clinical laboratory value were BMI (n=42), VO 2max (n=41), SBP
(n=41), DBP (n=41), total cholesterol (n=36), LDL-C (n=36), HDL-C (n=36), triglycerides (n=36),
and fasting blood glucose (n=34). The data used for each vascular health variable were FMD
testing (n=26), NO (n=24), CD62E+ EMPs (n=28), CD31+ 42- EMPs (n=28), CRP (n=37), IL-6
(n=32), and IL-10 (n=26). The differences in sample sizes of each variable are related to issues
such as inability to schedule subjects, failure to acquire blood samples, or faulty assa y
procedures.
Data are expressed as mean ± the standard error of the mean (SEM). The distribution of all
variables was examined using the Shapiro-Wilk test of normality. Pre- and Post-AEXT were
compared using the paired samples Wilcoxon signed-rank test. Spearman’s Rho was used to
calculate correlations between the adherence measures and the changes in clinical values as well
as changes in vascular health biomarkers. Statistical significance was set at a p-value of <0.05.
All statistical analyses were performed using SPSS version 21.0 (SPSS Inc., Chicago, IL).
RESULTS
The study group consisted of 42 African American men (n=6; 14.3%) and women (n=36; 85.7%).
The mean age of the group was 52.7 ± 1.0 year. Ideal adherence would have been defined as a
subject achieving an exercise percentage of 100%, resulting in an exercise volume of 2730.0
minutes and an exercise score of 113.8. The calculated adherence variables included the
following: exercise percentage (81.6 ± 2.0%; range: 61.0 - 100.0%), exercise volume (2920.8 ± 86.8
min; range: 2330.0 - 4650.0 min), and exercise score (98.0 ± 2.8; range: 69.3 - 166.1).
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The clinical laboratory values of the participants measured prior and subsequent to the AEXT
intervention are presented in Table 1. The 6-month AEXT intervention significantly increased
VO2max and significantly decreased BMI, plasma triglycerides, and fasting blood glucose. Total
cholesterol, LDL cholesterol, HDL cholesterol, and mean systolic and diastolic blood pressure
were not significantly changed following the AEXT intervention.
Table 1: Clinical laboratory values of subjects Pre- and Post-AEXT.
Variable
Subject Number
Pre-AEXT
Post-AEXT
Percent Change
2
BMI (kg/m )
n=42
31.4 ± 0.9
30.6 ± 0.8*
-2.5%
VO2max (mL/kg/min)
25.9
±
0.9
28.2
±
1.1**
n=41
8.9%
SBP (mm Hg)
124.2 ± 1.9
123.6 ± 2.2
n=41
-0.5%
DBP (mm Hg)
78.7 ± 1.1
78.9 ± 1.2
n=41
0.3%
TCH (mg/dL)
192.1 ± 4.3
191.4 ± 5.1
n=36
-0.4%
LDL-C (mg/dL)
108.7 ± 3.6
111.9 ± 4.3
n=36
2.9%
HDL-C (mg/dL)
66.8
±
3.3
65.6
±
3.4
n=36
-1.8%
Triglycerides (mg/dL)
83.0 ± 5.7
70.1 ± 3.3**
n=36
-15.5%
FBG (mg/dL)
95.1 ± 1.7
88.5 ± 1.8**
n=34
-6.9%
Subject number represents usable sample for variables.
Values are expressed as mean ± SEM. BMI, body mass index; VO 2max, maximal oxygen uptake; SBP, systolic
blood pressure; DBP, diastolic blood pressure; TCH, total cholesterol; LDL-C, low- density lipoprotein cholesterol;
HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose.
*Denotes significant differences; p < 0.05
**Denotes significant differences; p < 0.01

The vascular health biomarkers: FMD, NO, CD62E+ EMP, CD31+42 - EMP, CRP, IL-6, and IL10, considered indices of vascular health, were measured prior and subsequent to the AEXT
intervention and are presented in Table 2. The 6-month AEXT intervention significantly
increased FMD and NO and significantly decreased CD62E+ EMPs, CD31+CD42- EMPs, CRP,
and IL-6. There was an increase in IL-10 following the AEXT intervention; however, the
increase was not significant.
Table 2: Vascular health biomarkers of subjects Pre- and Post-AEXT.
Subject Number
Pre-AEXT
Post-AEXT
Percent Change
Variable
FMD (%)
6.0
±
0.6
9.6
±
0.4**
n=26
60%
NO (µmol/L)
n=24
23.7 ± 1.8
37.1 ± 3.2**
56.5%
CD62E+EMP (events/µL)
n=28
42.5 ± 5.3
22.4 ± 3.8**
-47.3%
CD31+42-EMP (events/µL)
n=28
3.6 ± 0.4
2.2 ± 0.3**
-38.9%
CRP (mg/L)
n=37
3.3 ± 0.5
2.8 ± 0.5*
-15.2%
IL-6 (pg/mL)
n=32
5.0 ± 0.2
4.4 ± 0.4*
-12%
IL-10 (pg/mL)
n=26
0.81 ± 0.06
0.85 ± 0.06
4.9%
Subject number represents usable sample for variables.
Values are expressed as mean ± SEM.
FMD, flow mediated dilation; NO, nitric oxide, EMP, endothelial microparticle; CRP, C-reactive protein; IL-6,
interleukin-6; IL-10, interleukin-10.
*Denotes significant differences; p < 0.05
**Denotes significant differences; p < 0.01
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Correlations between adherence measures and delta variables are presented in Table 3. There
was a significant positive correlation between exercise volume and the change in systolic blood
pressure, and a significant positive correlation between exercise score and the change in HDL
cholesterol subsequent to the AEXT intervention. There were no other significant correlations
between any of the adherence measures and the changes in clinical values of the participants.
Changes in vascular health biomarkers were not significantly correlated with any of the
adherence measures.
Table 3: Correlations between adherence measures and changes in variables Pre-Post AEXT.
Delta Variable
Exercise Percentage
Exercise Volume
Exercise Score
BMI (kg/m2)
-0.143
0.147
-0.089
VO2max (ml/kg/min)
0.226
-0.111
-0.037
VO2max
(ml/kg/min)
(ml/kg/min)
0.226
-0.111
-0.037
SBP (mm Hg)
-0.136
0.331*
0.106
DBP (mm Hg)
0.010
0.107
0.013
TCH (mg/dL)
0.016
0.258
0.118
LDL-C (mg/dL)
-0.046
0.160
-0.058
HDL-C (mg/dL)
0.166
0.281
0.400*
Triglycerides (mg/dL)
-0.105
0.002
-0.149
FBG (mg/dL)
0.016
-0.180
-0.275
FMD (%)
-0.267
0.325
0.017
NO (µmol/L)
-0.118
0.345
0.080
CD62E+EMP (events/µL)
0.005
0.317
0.334
CD31+42-EMP (events/µL)
0.277
-0.111
0.054
CRP (mg/L)
0.213
-0.152
-0.065
IL-6 (pg/mL)
0.116
-0.091
0.017
IL-10 (pg/mL)
-0.029
0.214
0.336
BMI, body mass index; VO2max, maximal oxygen uptake; SBP, systolic blood pressure; DBP, diastolic blood
pressure; TCH, total cholesterol; LDL-C, low- density lipoprotein cholesterol; HDL-C, high-density lipoprotein
cholesterol; FBG, fasting blood glucose; FMD, flow mediated dilation; NO, nitric oxide; EMP, endothelial
microparticle; CRP, C-reactive protein; IL-6, interleukin-6; IL-10, interleukin-10.
*Denotes significant differences; p < 0.05

DISCUSSION
Research data have demonstrated that significant physiological adaptations may occur
subsequent to AEXT interventions (3, 5, 9, 22, 25, 29, 30). The results from the present study
expand upon our previous findings that AEXT is a nonpharmacologic treatment modality that
may improve health and reduce cardiovascular risk in middle-to-older aged African American
adults free from overt cardiovascular disease. Specifically, we have reported that AEXT
demonstrated improvements in both clinical outcome measures as well as vascular health
markers (2, 14, 35). As a complement to this previous work, the present study was designed to
elucidate whether levels of exercise adherence played a significant role in the favorable
physiological adaptations in this African American cohort. The primary findings of this study
revealed that the significant improvements in clinical and vascular health measures pre-post
AEXT in this cohort were not associated with any of the measured levels of exercise adherence.
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The minimal significant associations between the adherence measures and clinical health
measures did not include any of the clinical health measures that were significantly changed
pre-post AEXT. To our knowledge, this study is novel because it is the first study that has
evaluated relationships between measured indices of exercise adherence and improvements in
physiological markers subsequent to AEXT in a middle-to-older aged African American cohort.
Exercise adherence is not uniformly quantified in clinical research; therefore, this should be
taken into account when interpreting and comparing study findings. Currently, there is no gold
standard in adherence measurement (6, 32); however, Miller and colleagues suggest that
quantifying adherence as cumulative exercise exposure, rather than simply sessions attended,
may yield more accurate outcome data (24). Adherence in clinical trials has been measured a
number of ways, including pedometry (13), accelerometry (11), self-monitoring through exercise
diaries (23), dividing kilocalories expended by kilocalories prescribed (8, 11), and calculating
minutes completed within prescribed target heart rate range divided by total minutes prescribed
(18). The results of the aforementioned studies collectively have demonstrated favorable
outcomes in body composition, clinical markers, and aerobic fitness levels.
Lack of adherence to clinical exercise interventions is another factor contributing to the difficulty
in assessing adherence. A number of demographic, physiological, and psychological factors are
associated with one’s adherence to an exercise program, including cardiovascular disease risk,
body mass index, exercise enjoyment, past exercise behavior, social support, and self-efficacy
for exercise (10, 33, 36). Several strategies for enhancing adherence have been identified,
including cognitive behavioral, social support, and programming approaches. One of the
strategies utilized in this intervention was to gradually increase the duration and intensity of
exercise throughout the program in order to minimize pain and fatigue, and to maximize
feelings of exercise self-efficacy. Additionally, tokens for public transit, as well as
complimentary parking, were provided in order to enhance convenience.
In the present study, the amount of exercise each subject completed was objectively quantified
by recording frequency and duration, and heart rate monitoring was used to assess intensity.
Furthermore, exercise adherence was calculated three ways in order to comprehensively
measure and assess the relationship between exercise adherence and physiological adaptations
to exercise. The first method of measuring adherence, exercise percentage, was calculated by
dividing 24 (the number of weeks comprising the exercise prescription) by the number of weeks
it took each subject to complete the 24-week program. If participants did not attend at least two
sessions in a given week, they would be required to repeat that week’s exercise prescription. A
minimum level of 60% adherence percentage was required to continue in the program. This
method took into account the adaptations that occur from regular exercise training, as well as
the detraining effects that may occur from interrupted participation.
The second method of measuring adherence, exercise volume, was measured by calculating the
total minutes of exercise each participant completed while enrolled in the study. Participants
who took longer to complete the program typically obtained higher exercise volume scores due
to repeating the exercise prescription for specific weeks where they may not have met the
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requirements for 2-3 sessions in a given week. According to the ACSM, it is recommended that
most adults engage in moderate-intensity cardiorespiratory exercise training for a total of ≥150
minutes per week; however, the exercise program should be modified according to an
individual’s health status, physical function, habitual physical activity, exercise responses, and
stated goals (15). In addition, adults who are unwilling or unable to meet the exercise targets
outlined in ACSM’s Position Stand may still benefit from engaging in amounts of exercise less
than recommended (15). Therefore, this measure of adherence considered whether the total
number of minutes achieved by this African American cohort was adequate to elicit favorable
physiological adaptations.
In order to account for the variable amount of time it took the participants to complete the 24 week equivalent exercise training program, a third method of measuring adherence was created
and each participant’s exercise score was determined. This measure was calculated by dividing
each participant’s total exercise minutes (exercise volume) by the actual number of weeks it took
the participant to complete the program. This final method of calculating adherence took into
account the frequency of exercise participation, given that participants worked at uniform
intensities (beginning at 50% VO 2max and working up to 65% VO 2max). Exercise intensity was
closely regulated with study personnel recording participants’ exercise heart rates every 10
minutes to ensure they were working at their prescribed intensities. This measurement
permitted exercise dose (i.e., intensity, duration, and frequency) to be closely monitored, which
is necessary in order to amply interpret outcome variables (26). As previously noted, the exercise
scores of participants who were required to repeat weeks of exercise may have been impacted
by their higher exercise volumes.
While statistically significant improvements following AEXT in both clinical and vascular health
measures were observed in this African American cohort, these improvements were not related
to the participants’ levels of adherence to the exercise prescription. Only two clinical variables
were significantly correlated with exercise adherence in the present study: systolic blood
pressure and HDL cholesterol. Systolic blood pressure was positively correlated with exercise
volume (total minutes); however, there was no relationship between systolic blood pressure and
exercise percentage or exercise score. HDL cholesterol was positively correlated with exercise
score, but not exercise percentage or exercise volume. The findings demonstrated that there were
no statistically significant differences in systolic blood pressure and HDL cholesterol pre-post
AEXT. Further analysis revealed Cohen’s effect size value for the change in systolic blood
pressure (d=0.06) and the change in HDL cholesterol (d=0.14), and also suggests low practical
significance. In addition, none of the vascular health markers were significantly correlated with
any exercise adherence measure. Exercise adherence in this population at levels lower than
recommended in ACSM’s Position Stand may prove to have clinical and vascular health
benefits.
Results from the present study indicate that participants benefited from AEXT regardless of their
individual level of exercise adherence as defined in this study. Exercise adherence is often
difficult to quantify; thus adherence was conceptualized three separate ways in order to
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comprehensively measure the construct. These adherence measures were created to
complement the experimental design of the present study. Participants in this study improved
their vascular health and decreased their risk factors for cardiovascular disease, and these
favorable alterations were not associated with the measured indices of adherence to the exercise
prescription. This suggests that the axiom, some exercise is better than none, may be particularly
true when working with members of this at-risk population. Future studies should continue to
accurately quantify adherence in order to assess the exercise dose for improvement in vascular
and clinical health.
As previously mentioned, findings from this study demonstrate little significance between
levels of exercise adherence and changes in physiological outcomes; however, the current
study had a number of limitations that should be addressed. First, the study sample size was
relatively small, but this was due to the exclusions to create a more homogenous group in order
to eliminate confounding variables that may influence clinical or vascular health markers.
Despite the small sample size, significant changes were observed in four clinical outcomes and
all but one vascular health marker. Second, it is important to consider that while levels of
adherence varied among participants in the current study, participants who were unable to
make satisfactory progress toward completion of the program (i.e., not attending at least 60%
of sessions) were asked to discontinue participation in the study. Based on the literature, it is
reasonable to deduce that excluded participants that fell below this study’s minimum
adherence requirements would not have experienced similar improvements in clinical and
vascular health measures (23, 26, 36). Finally, the sample population was predominantly female
African Americans; therefore, our findings may not be generalizable to African American
males or other ethnic populations.
Accurately measuring adherence is essential because one must engage in ample AEXT (e.g.,
frequency, intensity, duration) in order for physiological adaptations to occur, and ultimately,
to receive health benefits. In the present study, improvements in clinical and vascular health as
a result of AEXT were observed regardless of the variation in the exercise adherence indices
measured; however, all of the participants in this cohort met the minimum requirements for
adherence as outlined in the study. Given the lack of correlations between levels of exercise
adherence and significant improvements in clinical and vascular health measures, achieving
high levels of adherence may have less merit; however, this warrants further investigation.
Future studies should further examine the role of adherence in the dose-response relationship
between AEXT and clinical and vascular health outcomes. Based on these findings, participating
in a regular AEXT program below published guidelines for healthy populations in order to
achieve minimum physiological benefits may result in unforeseen clinical and/or physiological
beneficial effects in certain populations.
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